When the patient develops chronic pancreatitis with maldigestion, diabetes and pain, we can offer enzyme-replacement therapy, insulin and analgesics. Various surgical and endoscopic procedures ...
US FDA clears expanded use of Alcresta Therapeutics’ RELiZORB cartridge for paediatric patients 1 year of age and older: Waltham, Massachusetts Friday, January 17, 2025, 17:00 H ...
Israeli and American researchers uncovered the role of a specific enzyme in managing blood sugar levels in a study that opens up new therapeutic possibilities for people with type 2 diabetes. Type 2 ...
VIVUS will be discussing its significant 2024 momentum during the J.P. Morgan Healthcare Conference, with an emphasis on what we as a company aim to achieve during the coming months around our novel ...